| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.005 |